| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d121b8ef864cae4556f46805d20bc3d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b1416c6e66e0ade5429212414964
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ca30f9e22af04e7385117086aa7434a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1116b786c655c927d2601b6b641fe293
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de0f70596c4e0971da8fd142acf99409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_978b0e2d862e6646bb11e52d395c5c3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e10b67dbbcb424328ed8fbfe68019b44 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 |
| filingDate |
2001-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89bad826bfcdd6b1eb46e947d1dea76e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_741e894a6ce0b1ec75a2cbc6b39a73f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45b3bc7eef4fc56b1c996ffc98fac9e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adaaf55bcef53970e4d004171a871cbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_036dbe764cd2a8ec8b9e86f99c0cca16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0422a496e59f8619f0b2009046e4e645 |
| publicationDate |
2003-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0236558-A3 |
| titleOfInvention |
Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation |
| abstract |
The present invention provides novel ondansetron hydrochloride crystalline polymorphic forms and solvates. Processes for making and interconverting the polymorphic forms are also provided. Further provided are pharmaceutical compositions and therapeutic methods using the novel polymorphic forms and hydrates. |
| priorityDate |
2000-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |